News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
858,366 Results
Type
Article (87421)
Company Profile (739)
Press Release (770188)
Multimedia
Podcasts (197)
Webinars (28)
Section
Business (232770)
Career Advice (4143)
Deals (39874)
Drug Delivery (144)
Drug Development (91179)
Employer Resources (205)
FDA (18255)
Job Trends (17422)
News (396858)
Policy (39845)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3002)
Academic (1)
Accelerated approval (31)
Adcomms (30)
Allergies (120)
Alliances (56794)
ALS (154)
Alzheimer's disease (1752)
Antibody-drug conjugate (ADC) (312)
Approvals (18368)
Artificial intelligence (469)
Autoimmune disease (160)
Automation (31)
Bankruptcy (402)
Best Places to Work (12512)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (457)
Bladder cancer (145)
Brain cancer (52)
Breast cancer (539)
Cancer (4282)
Cardiovascular disease (301)
Career advice (3568)
Career pathing (41)
CAR-T (292)
CDC (36)
Celiac Disease (1)
Cell therapy (764)
Cervical cancer (29)
Clinical research (76119)
Collaboration (1607)
Company closure (4)
Compensation (998)
Complete response letters (64)
COVID-19 (2927)
CRISPR (85)
C-suite (737)
Cystic fibrosis (143)
Data (5420)
Decentralized trials (2)
Denatured (73)
Depression (114)
Diabetes (342)
Diagnostics (6977)
Digital health (23)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (252)
Drug pricing (161)
Drug shortages (19)
Duchenne muscular dystrophy (200)
Earnings (98004)
Editorial (57)
Employer branding (25)
Employer resources (174)
Events (132821)
Executive appointments (825)
FDA (20626)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (24)
Funding (1272)
Gene editing (183)
Generative AI (46)
Gene therapy (606)
GLP-1 (931)
Government (5325)
Grass and pollen (4)
Guidances (276)
Healthcare (20778)
HIV (43)
Huntington's disease (46)
IgA nephropathy (79)
Immunology and inflammation (267)
Immuno-oncology (59)
Indications (81)
Infectious disease (3148)
Inflammatory bowel disease (204)
Inflation Reduction Act (14)
Influenza (96)
Intellectual property (198)
Interviews (816)
IPO (17808)
IRA (45)
Job creations (5198)
Job search strategy (2866)
JPM (66)
Kidney cancer (16)
Labor market (92)
Layoffs (639)
Leadership (37)
Legal (10091)
Liver cancer (87)
Longevity (13)
Lung cancer (586)
Lymphoma (332)
Machine learning (41)
Management (66)
Manufacturing (716)
MASH (159)
Medical device (14421)
Medtech (14451)
Mergers & acquisitions (22745)
Metabolic disorders (1066)
Multiple sclerosis (154)
NASH (22)
Neurodegenerative disease (330)
Neuropsychiatric disorders (79)
Neuroscience (2901)
Neurotech (1)
NextGen: Class of 2026 (7686)
Non-profit (5080)
Now hiring (65)
Obesity (522)
Opinion (326)
Ovarian cancer (151)
Pain (153)
Pancreatic cancer (170)
Parkinson's disease (260)
Partnered (33)
Patents (396)
Patient recruitment (419)
Peanut (56)
People (66286)
Pharmaceutical (133)
Pharmacy benefit managers (20)
Phase 1 (23599)
Phase 2 (33128)
Phase 3 (24817)
Pipeline (4318)
Policy (283)
Postmarket research (3544)
Preclinical (10586)
Press Release (72)
Prostate cancer (203)
Psychedelics (51)
Radiopharmaceuticals (279)
Rare diseases (797)
Real estate (7423)
Recruiting (81)
Regulatory (28240)
Reports (63)
Research institute (2695)
Resumes & cover letters (651)
Rett syndrome (21)
RNA editing (21)
RSV (63)
Schizophrenia (139)
Series A (225)
Series B (162)
Service/supplier (25)
Sickle cell disease (85)
Special edition (27)
Spinal muscular atrophy (175)
Sponsored (47)
Startups (4323)
State (2)
Stomach cancer (14)
Supply chain (74)
Tariffs (76)
The Weekly (122)
Vaccines (1001)
Venture capital (91)
Weight loss (339)
Women's health (71)
Worklife (22)
Date
Today (71)
Last 7 days (461)
Last 30 days (1692)
Last 365 days (25306)
2026 (2473)
2025 (25543)
2024 (34032)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1279)
Alabama (85)
Alaska (6)
Arizona (288)
Arkansas (8)
Asia (51129)
Australia (9003)
California (9732)
Canada (2478)
China (1061)
Colorado (306)
Connecticut (390)
Delaware (295)
Europe (116918)
Florida (1259)
Georgia (253)
Hawaii (4)
Idaho (65)
Illinois (652)
India (56)
Indiana (447)
Iowa (21)
Japan (341)
Kansas (133)
Kentucky (25)
Louisiana (14)
Maine (59)
Maryland (1258)
Massachusetts (7320)
Michigan (244)
Minnesota (453)
Mississippi (5)
Missouri (79)
Montana (28)
Nebraska (29)
Nevada (106)
New Hampshire (57)
New Jersey (2555)
New Mexico (29)
New York (2555)
North Carolina (1413)
North Dakota (9)
Northern California (4778)
Ohio (257)
Oklahoma (18)
Oregon (51)
Pennsylvania (1874)
Puerto Rico (22)
Rhode Island (33)
South America (1658)
South Carolina (13)
South Dakota (1)
Southern California (3756)
Tennessee (58)
Texas (1364)
United States (33840)
Utah (209)
Vermont (1)
Virginia (168)
Washington D.C. (54)
Washington State (818)
West Virginia (2)
Wisconsin (82)
858,366 Results for "cabaletta bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 5, 2026
·
1 min read
Press Releases
Cabaletta Bio Announces 2026 Strategic Priorities
January 12, 2026
·
12 min read
Press Releases
IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares’ Automated Platforms
January 12, 2026
·
5 min read
Press Releases
Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December 2025
November 5, 2025
·
2 min read
Press Releases
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
November 10, 2025
·
14 min read
FDA
JPM26: Beam, Cabaletta, More Zero In on Regulatory Alignment After Tumultuous Year
As biotechs faced investors at the J.P. Morgan Healthcare Conference this week, they emphasized agreement with the FDA on clinical trial design and regulatory pathways to approval. Atara, meanwhile, lamented the agency’s “complete reversal of position” after its therapy for a rare surgical complication was rejected.
January 19, 2026
·
6 min read
·
Heather McKenzie
Press Releases
Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025
October 27, 2025
·
13 min read
Press Releases
Cabaletta Bio Announces Appointment of Steve Gavel as Chief Commercial Officer and Award of Inducement Grant
October 15, 2025
·
7 min read
Press Releases
Cabaletta Bio to Participate in Upcoming Investor Conferences in September 2025
August 28, 2025
·
2 min read
Press Releases
Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress
October 10, 2025
·
11 min read
1 of 85,837
Next
